Frostbite is a serious cold injury that affects millions worldwide, often resulting in prolonged recovery, scars and long -term complications such as chronic pain and malfunction. The injury usually begins with cell death caused by cold, localized inflammation and tissue ischemia, which disrupts the ability of the skin to heal. Current treatments, such as calcium canal inhibitors, function limit the prevention of scarring and often do not deal with underlying damage to skin cells and extracellular uterus (ECM). These weaknesses emphasize the urgent need for innovative treatments capable of accelerating treatment, reducing inflammation and restoring normal skin function. Research on new treatments is vital to the treatment of the complex pathology of Frostbite and its long -term effects.
On October 4, 2024, researchers from Peking Union Medical College Hospital and the National Protein Science Center (Beijing) published a study (DOI: 10.1093/PROCEL/PWAE055) in Protein and hive This explores the potential of humans induced by humans caused by humans caused by humans to treat cryopresa injuries. This study provides valuable knowledge about the regenerative ability of these skin organoids and their ability to facilitate the healing of wounds without a sphere.
The researchers developed a Frostbite mouse model to better understand the healing process and cellular responses. Using transcriptional monocytes, they followed dynamic changes in various cell types, including monocytes, macrophages, epidermal cells and fibroblasts. The analysis revealed intense inflammation and tissue damage in the early stages of cryopagine, characterized by increased immunocytic infiltration and ECM disorder. To address these issues, the researchers designed HIPSC skin organoids in combination with gelatin-hydrogel and transplant them into mice injured by a cryopal.
The results showed that these skin organoids significantly accelerate the healing of wounds by alleviating early inflammation by decreasing inflammatory cytokines (eg CCL4 and IL6) and promoting the proliferation of epidermal stem cells. Later in the healing process, the organoids adjusted the pathway of Integrine A5B1-FAK, reducing the transition of fibroblasts to myoinoblasts and the remodeling of ECM to prevent abnormal scar formation. Specifically, the organoids restored normal ECM, paving the way for a sphere -free treatment. This discovery not only faces the unique challenges of Frostbite, but also offers a possible solution to treat a series of other complex skin injuries.
Dr. Ling Leng, one of the corresponding authors, emphasized the importance of their findings: our study shows that skin organoids can effectively shape the inflammatory response and promote rapid healing of wounds in cryopresum injuries. This opens new opportunities for the treatment of complex wounds and prevent long -term complications.
The application of the organism of the skin for the treatment with a cryoprite represents a significant progress in regenerative medicine. By accelerating wound healing and inhibiting scars, these skin organoids offer a very promising solution for patients suffering from severe cryopresum injuries. Their ability to shape inflammation and restore normal skin function fills a critical gap in current treatments, which often fail to deal with long -term complications. Future research will focus on optimizing techniques for transplanting skin organizations and expanding their potential for the treatment of other complex skin diseases, such as burns and chronic wounds. This discovery has the ability to promote wound care, improve the effects of patients and enhancing the quality of life.
Source:
Magazine report:
Wang, W., et al. (2024). Organic skin transplantation promotes tissue repair with inappropriate trap. Protein and hive. doi.org/10.1093/procel/pwae055.
